Weight loss
Every post on weight loss, newest first.
Posts
Studies5 min read
Tirzepatide users stay on treatment longer than semaglutide users
Three real-world studies looked at [tirzepatide](/peptides/tirzepatide) in routine care. They found higher adherence than semaglutide, Zepbound had the most super responders, and lithium monitoring matters.
Studies4 min read
What the studies show about AOD-9604 in 2026
AOD-9604 is a lab-made growth hormone fragment. In 2026, animal studies still show fat loss without insulin effects, but human research stopped at early safety reports.
Compound pages
The evergreen research summaries these posts build on.
TirzepatideDual GIP/GLP-1 receptor agonist for weight loss and glycemic control.LiraglutideA once-daily GLP-1 injection approved for weight loss and diabetes.DulaglutideOnce-weekly GLP-1 agonist for type 2 diabetes and heart-risk reduction.ExenatideA GLP-1 receptor agonist studied for diabetes and weight.AOD-9604A growth-hormone fragment studied for fat loss without insulin effects.HGH Fragment 176-191A fat-mobilizing slice of growth hormone, studied for fat loss.